17.03.2011 • NewsJames O'BrienAshlandPeople

James O'Brien to Have Colon Surgery

Ashland head James OBrien is expected to be out for two to three months...
Ashland head James O'Brien is expected to be out for two to three months following colon surgery.

Specialty chemicals company Ashland on Wednesday said Chairman and Chief Executive James O'Brien will have surgery to fix a perforated colon and be out for two to three months.

The company said he would be available on "a limited basis" until his full return.

Lead director Barry Perry will be interim chairman, while CFO Lamar Chambers and general counsel David Hausrath will assume his executive duties, Ashland said.

Separately, the company said it would repurchase $400 million in shares and that it intends to raise its annual dividend to 70 cents per share from 60 cents per share, beginning with the June 15 dividend payment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.